Rethinking Brain Health: A Systems Approach to Preventing Cognitive Decline

Preventing Cognitive Decline: A Multi-Axis, Systems-Based Approach

The Cognitive Brain

Cognitive decline represents one of the most feared consequences of aging—not simply because of memory loss, but because it erodes identity, independence, and the essence of self. While Alzheimer’s disease and related dementias are often framed as inevitable consequences of aging, a growing body of evidence challenges this deterministic view. Cognitive decline is not a singular disease process but rather the culmination of multiple interacting biological insults: metabolic dysfunction, vascular injury, chronic inflammation, mitochondrial failure, oxidative stress, and impaired proteostasis.

Importantly, many of these processes begin decades before the first clinical symptoms appear. This long preclinical phase presents a critical opportunity: cognitive decline is, at least in part, preventable and modifiable.

Emerging evidence supports a multi-domain, systems-based prevention strategy, analogous to the “multi-axis metabolic pressure” model increasingly applied in oncology. Just as cancer cells adapt to single-agent therapies, the aging brain resists simplistic, single-intervention approaches. Effective prevention requires coordinated interventions targeting multiple biological pathways simultaneously.

---

Pathophysiology of Cognitive Decline: A Systems View

Cognitive decline arises from the convergence of several interrelated biological processes:

1. Metabolic Dysfunction and Insulin Resistance

The brain is a metabolically demanding organ. Impaired glucose utilization—sometimes termed “type 3 diabetes”—is a hallmark of early Alzheimer’s disease. Insulin resistance reduces neuronal energy availability, promotes amyloid aggregation, and accelerates tau phosphorylation.

2. Mitochondrial Dysfunction

Mitochondria are central to neuronal survival. Aging is associated with reduced mitochondrial biogenesis, increased reactive oxygen species (ROS), and impaired ATP production. These changes render neurons vulnerable to degeneration.

3. Neuroinflammation

Chronic activation of microglia leads to a sustained inflammatory state characterized by cytokines such as IL-1β, TNF-α, and IL-6. While acute inflammation is protective, chronic inflammation contributes to synaptic dysfunction and neuronal loss.

4. Vascular Dysfunction

Cerebral small vessel disease, endothelial dysfunction, and impaired cerebral perfusion are major contributors to cognitive decline. Vascular pathology often coexists with neurodegenerative pathology.

5. Oxidative Stress

An imbalance between ROS production and antioxidant defenses leads to lipid peroxidation, DNA damage, and protein dysfunction.

6. Impaired Proteostasis

Accumulation of misfolded proteins—amyloid-β and tau—is a defining feature of Alzheimer’s disease, reflecting failure of cellular clearance systems such as autophagy.

---

Epidemiology and Risk Factors

Cognitive decline and dementia affect tens of millions worldwide, with prevalence expected to rise dramatically due to aging populations. However, epidemiological studies suggest that up to 40% of dementia cases may be preventable through modification of key risk factors.

Major modifiable risk factors include:

• Midlife hypertension

• Obesity and metabolic syndrome

• Type 2 diabetes

• Physical inactivity

• Smoking

• Depression

• Social isolation

• Hearing loss

• Poor sleep

These risk factors converge on common biological pathways—particularly metabolic dysfunction and inflammation.

A Multi-Axis Framework for Prevention

A useful conceptual model is to view cognitive decline through interacting axes, like systems biology frameworks:

1.Exercise

Exercise is arguably the most powerful intervention for preserving cognitive function.

Mechanisms:

• Increases brain-derived neurotrophic factor (BDNF)

• Enhances neurogenesis (particularly in the hippocampus)

• Improves insulin sensitivity

• Reduces inflammation

Evidence:

Randomized trials demonstrate that aerobic and resistance training improve executive function, memory, and processing speed.

Practical recommendation:

• 150–300 minutes/week aerobic activity

• Resistance training 2–3 times/week

---

2. Nutrition and Metabolic Health

Diet plays a central role in cognitive preservation.

Key principles:

• Minimize refined carbohydrates and sugar

• Emphasize whole, unprocessed foods

• Adequate protein intake

• Healthy fats (olive oil, omega-3 fatty acids)

Dietary patterns with evidence:

• Mediterranean diet

• MIND diet

• Ketogenic or low-carbohydrate diets (in selected individuals)

Mechanisms:

• Improves insulin sensitivity

• Reduces oxidative stress

• Promotes ketone utilization (an efficient brain fuel)

A large study published in 2022 showed that higher consumption of ultra-processed foods was related to a higher risk of dementia. (1) These common foods — including soft drinks, potato chips and other salty snacks, deep-fried or packaged meats, bottled condiments, prepackaged sweets and breads, and flavored breakfast cereals — are high in added sugar, fat, and salt, and low in protein and fiber. Participants were divided into four groups based on how much ultra-processed food they ate, and they were tracked for a decade. While none had dementia at the start of the study, the risk for Alzheimer’s rose 14% for every 10% increase in ultra-processed foods consumed; for dementia overall, the risk increased by 25%. (2)

---

3. Sleep Optimization

Sleep is essential for brain maintenance.

Mechanisms:

• Activation of the glymphatic system

• Clearance of amyloid-β

• Memory consolidation

Clinical relevance:

Growing evidence shows that getting quality sleep is correlated with improved brain health. The glymphatic system — a waste clearance system active in the central nervous system during the first half of the night, in slow wave sleep — is a major ‘power wash,’ for the brain, clearing it of all the toxins from a day of activity. Poor sleep affects our ability to make decisions, solve problems, and control our emotions. Sleep deprivation can increase the risk of chronic health problems such as high blood pressure, obesity, and heart disease. Chronic sleep deprivation is strongly associated with increased dementia risk.

---

4. Cognitive and Social Engagement

Cognitive stimulation builds cognitive reserve, delaying clinical manifestations of neurodegeneration.

Effective strategies:

• Learning new skills

• Reading and problem-solving

• Social interaction

---

Pharmacologic and Nutraceutical Strategies

While lifestyle interventions remain foundational, several agents show promise in targeting key biological pathways.

1. Metabolic Modulators

• Metformin: Improves insulin sensitivity; observational data suggest reduced dementia risk

• Berberine: Similar metabolic effects; additional anti-inflammatory properties

2. Anti-inflammatory and Antioxidant Agents

• Omega-3 fatty acids: Reduce neuroinflammation; support membrane integrity

• Curcumin: Anti-inflammatory, anti-amyloid properties

• Resveratrol: Activates sirtuins; supports mitochondrial function

3. Neurohormonal and Circadian Modulators

• Melatonin: Regulates circadian rhythm; antioxidant

• Vitamin D: Neuroprotective and immunomodulatory

4.Magnesium Threonate

• Magnesium protects against high levels of glutamate excitotoxicity and helps to raise GABA, the calming neurotransmitter. Most people are deficient in magnesium; therefore, supplementation is recommended in some form.

5. Green tea (EGCG)

• EGCG, a type of polyphenol antioxidant found in a variety of tea leaves including green tea, can prevent or delay the amyloidogenic process. There is evidence for EGCG’s ability to inhibit the aggregation of α-synuclein, amyloid-β, and huntingtin proteins, respectively associated with Parkinson’s, Alzheimer’s, and Huntington’s diseases. EGCG also has anti-platelet effects, which can prevent micro-clotting. (3, 4)

---

Vascular Risk Reduction

Control of vascular risk factors is critical:

• Blood pressure optimization

• Smoking cessation

• Glycemic control

Vascular pathology is present in the majority of dementia cases, often synergizing with neurodegenerative processes.

---

Emerging Concepts

1. The Gut–Brain Axis

Alterations in the microbiome influence inflammation, neurotransmitter production, and metabolic signaling.

The gut-brain axis is a fascinating and increasingly studied area in both neuroscience and gastroenterology. It refers to the bidirectional communication network that links the central nervous system (which includes the brain and spinal cord) with the enteric nervous system (the nervous system of the gastrointestinal tract). This relationship involves complex interactions through neural, endocrine (hormonal), immune, and metabolic pathways.

Emerging research also suggests a strong gut-brain link in mental health and that an imbalanced gut microbiome has been associated with cognitive decline. Conditions like anxiety, depression, and even autism spectrum disorder have been linked to imbalanced gut health.

The pursuit of optimal gut health is much more than a dietary trend; it’s a fundamental aspect of holistic health and wellbeing. By nurturing our gut health through a balanced diet rich in fiber, probiotics, and prebiotics, along with mindful lifestyle practices, we can support our mental and physical health in profound ways.

2. Intermittent Fasting

Fasting promotes:

• Autophagy

• Ketogenesis

• Mitochondrial biogenesis

Intermittent fasting has many brain benefits, including upregulating and increasing brain-derived neurotrophic factor (BDNF), lowering inflammation, reducing cortisol, and lowering insulin resistance. Fasting can trigger a cell-recycling process called autophagy, which helps our body remove damaged cells, including senescent cells.

3. Multimodal Interventions

Clinical trials demonstrate that combined interventions outperform single strategies.

---

Discussion

The traditional approach to dementia—waiting for symptoms and then attempting pharmacologic intervention—has largely failed. This reflects a fundamental misunderstanding: cognitive decline is not a late-stage disease but a decades-long process.

Prevention requires a paradigm shift:

• From treatment to early intervention

• From single targets to systems biology

• From pharmaceuticals alone to integrated strategies

---

Conclusion

Cognitive decline is not inevitable. It is the cumulative result of modifiable biological processes acting over time. By targeting these processes early—through lifestyle, metabolic optimization, and selected pharmacologic interventions—we can substantially reduce risk.

The most effective strategy is not a single intervention, but a coordinated, multi-domain approach that supports metabolic health, preserves mitochondrial function, reduces inflammation, and enhances neuroplasticity.

In this sense, preventing cognitive decline is not about treating disease, it is about maintaining the resilience of the brain.

---

Figure 1. Multi-axis approach to preventing cognitive decline

Medical Disclaimer: The discussion of repurposed medications and nutraceuticals in this article is intended to review the scientific literature and does not constitute a recommendation for self-treatment. Decisions regarding the use of off-label therapies should be made in consultation with a qualified healthcare professional familiar with the patient’s medical history and current treatment plan. Please see the full Medical Disclaimer on the introductory page to Marik’s Cancer & Metabolic Healing Playbook.

References

1. Li H, Li S, Yang H, Zhang Y, Zhang S, Ma Y, et al. Association of Ultraprocessed Food Consumption With Risk of Dementia. Neurology. 2022;99(10):e1056–e66.

2. Neurology AAo. Eating Ultra-Processed Foods May Increase Risk of Dementia. Nutrition; 2023.

3. Wang Y, Wu S, Li Q, Lang W, Li W, Jiang X, et al. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease. Frontiers in Pharmacology. 2022;13.

4. Fernandes L, Cardim-Pires TR, Foguel D, Palhano FL. Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases. Frontiers in Neuroscience. 2021;15.